284
Views
7
CrossRef citations to date
0
Altmetric
Reviews

Cardiovascular risk associated with sodium-containing medicines

, MBChB MSc MPH PhD, , PhD FRCP Edin, , MD FRCP & , MD FRCP

Bibliography

  • Brown IJ, Tzoulaki I, Candeias V, Elliott P. Salt intakes around the world: implications for public health. Int J Epidemiol 2009;38:791-813
  • Tuomilehto J. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 2001;357:848-51
  • Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ 1988;297:319-28
  • Midgley JP, Matthew AG, Greenwood CM, Logan AG. Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. JAMA 1996;275:1590-7
  • Graudal NA, Galloe AM, Garred P. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. JAMA 1998;279:1383-91
  • He FJ, MacGregor GA. Reducing population salt intake worldwide: from evidence to implementation. Prog Cardiovasc Dis 2010;52:363-82
  • Tobian L, Hanlon S. High sodium chloride diets injure arteries and raise mortality without changing blood pressure. Hypertension 1990;15:900-3
  • Cook NR, Cutler JA, Obarzanek E, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007;334:885-8
  • D’Elia L, Galletti F, Strazzullo P. Dietary salt intake and risk of gastric cancer. Cancer Treat Res 2014;159:83-95
  • Tsugane S. Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. Cancer Sci 2005;96:1-6
  • Peleteiro B, Lopes C, Figueiredo C, Lunet N. Salt intake and gastric cancer risk according to Helicobacter pylori infection, smoking, tumour site and histological type. Br J Cancer 2011;104:198-207
  • Nerbass FB, Pecoits-Filho R, McIntyre NJ, et al. Demographic associations of high estimated sodium intake and frequency of consumption of high-sodium foods in people with chronic kidney disease stage 3 in England. J Ren Nutr 2014;24(4):236-42
  • Smyth A, O’Donnell MJ, Yusuf S, et al. Sodium Intake and Renal Outcomes: a Systematic Review. Am J Hypertens 2014;27(10):1277-84
  • Graudal N, Jürgens G, Baslund B, Alderman MH. Compared with usual sodium intake, low- and excessive-sodium diets are associated with increased mortality: a meta-analysis. Am J Hypertens 2014;27(9):1129-37
  • Lee HS, Duffey KJ, Popkin BM. Sodium and potassium intake patterns and trends in South Korea. J Hum Hypertens 2013;27(5):298-303
  • Millett C, Laverty AA, Stylianou N, et al. Impacts of a national strategy to reduce population salt intake in England: serial cross sectional study. PLoS One 2012;7(1):e29836
  • CDC CfDCaP. MMWR Morb Mortal Wkly Rep. 2013;62:1021-5
  • Webster JL, Dunford EK, Hawkes C, Neal BC. Salt reduction initiatives around the world. J Hypertens 2011;29:1043-50
  • O’Flaherty M, Flores-Mateo G, Nnoaham K, et al. Potential cardiovascular mortality reductions with stricter food policies in the United Kingdom of Great Britain and Northern Ireland. Bull World Health Organ 2012;90:522-31
  • Report on dietary sodium intakes. Available from: www.gov.uk/government/news/report-on-dietary-sodium-intakes [Accessed on 31 July 2014]
  • Salt and Health. Available from: ww.sacn.gov.uk/pdfs/sacn_salt_final.pdf [Accessed on 31 July 2014]
  • NICE Public Health Guidance: prevention of cardiovascular disease. Available from: www.nice.org.uk/nicemedia/live/13024/49273/49273.pdf [Accessed on 31 July 2014]
  • WHO issues new guidance on dietary salt and potassium. Available from: www.who.int/mediacentre/news/notes/2013/salt_potassium_20130131/en/ [Accessed on 31 July 2014]
  • Sheng H-W. Sodium, chloride and potassium. In: Stipanuk M, editor. Biochemical and physiological aspects of human nutrition. W.B. Saunders Company; Philadelphia: 2000. p. 686-710
  • Food and Nutrition Board, Institute of Medicine. Sodium and chloride. dietary reference intakes for water, potassium, sodium, chloride, and sulfate. National Academies Press; Washington (DC): 2005. p. 269-423
  • Folkow B. Physiological aspects of primary hypertension. Physiol Rev 1982;62:347-504
  • Tzemos N, Lim PO, Wong S, et al. Adverse cardiovascular effects of acute salt loading in young normotensive individuals. Hypertension 2008;51:1525-30
  • Lim PO, Farquharson CA, Shiels P, et al. Adverse cardiac effects of salt with fludrocortisone in hypertension. Hypertension 2001;37:856-61
  • Frohlich ED. The salt conundrum: a hypothesis. Hypertension 2007;50:161-6
  • Kotliar C, Kempny P, Gonzalez S, et al. Lack of RAAS inhibition by high-salt intake is associated with arterial stiffness in hypertensive patients. J Renin Angiotensin Aldosterone Syst 2014. [ Epub ahead of print]
  • Aburto NJ, Ziolkovska A, Hooper L, et al. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ 2013;346:f1326- doi: 10.1136/bmj.f1326; Review
  • Dickinson KM, Clifton PM, Keogh JB. A reduction of 3 g/day from a usual 9 g/day salt diet improves endothelial function and decreases endothelin-1 in a randomised cross_over study in normotensive overweight and obese subjects. Atherosclerosis 2014;233:32-8
  • Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension 1996;27:481-90
  • Institute of Medicine. Strategies to reduce sodium intake in the United States. In: Henney JE, Taylor CL, Boon CS, editor. National Academies Press (US); Washington (DC): 2010
  • Centers for Disease Control and Prevention (CDC). Vital signs: food categories contributing the most to sodium consumption: United States, 2007-2008. MMWR Morb Mortal Wkly Rep 2012;61:92-8
  • James WP, Ralph A, Sanchez-Castillo CP. The dominance of salt in manufactured food in the sodium intake of affluent societies. Lancet 1987;329:426-9
  • Sources of Sodium in Your Diet. Available from: www.cdc.gov/salt/pdfs/sources_of_sodium.pdf [Accessed on 31 July 2014]
  • Antman EM, Appel LJ, Balentine D, et al. Stakeholder discussion to reduce population-wide sodium intake and decrease sodium in the food supply: a conference report from the American Heart Association Sodium Conference 2013 Planning Group. Circulation 2014;129(25):e660-79
  • Asaria P, Chisholm D, Mathers C, et al. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet 2007;370:2044-53. Review Erratum in Lancet 2007;370:2004
  • Bibbins-Domingo K, Chertow GM, Coxson PG, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010;362:590-9
  • He FJ, Li J, Macgregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 2013; doi: 10.1002/14651858.CD004937.pub2
  • Dunford E, Webster J, Woodward M, et al. The variability of reported salt levels in fast foods across six countries: opportunities for salt reduction. CMAJ 2012;184(9):1023-8
  • Prevention of cardiovascular disease. Available from: www.evidence.nhs.uk/evidence-update-50 [Accessed on 31 July 2014]
  • Dahl LK, Love RA. Evidence for relationship between sodium (chloride) intake and human essential hypertension. AMA Arch Intern Med 1954;94:525-31
  • Pimenta E, Gaddam KK, Oparil S, et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension 2009;54:475-81
  • Appel LJ, Frohlich ED, Hall JE, et al. The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation 2011;123:1138-43
  • MacGregor GA, Markandu ND, Sagnella GA, et al. Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet 1989;334:1244-7
  • Sacks FM, Svetkey LP, Vollmer WM, et al. DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet: DASH-Sodium Collaborative Research Group. N Engl J Med 2001;344:3-10
  • Vollmer WM, Sacks FM, Ard J, et al. DASH-Sodium Trial Collaborative Research Group. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med 2001;135:1019-28
  • Cappuccio FP, Markandu ND, Carney C, et al. Double-blind randomised trial of modest salt restriction in older people. Lancet 1997;350:850-4
  • He FJ, Li J, Macgregor GA. Effect of longer term modest salt reduction on blood pressure: cochrane systematic review and meta-analysis of randomised trials. BMJ 2013;346:f1325; Review
  • McMahon EJ, Bauer JD, Hawley CM, et al. A randomized trial of dietary sodium restriction in CKD. J Am SocNephrol 2013;24:2096-103
  • He FJ, MacGregor GA. Importance of salt in determining blood pressure in children: meta-analysis of controlled trials. Hypertension 2006;48:861-9. Review
  • He FJ, Pombo-Rodrigues S, MacGregor GA. Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke and ischaemic heart disease mortality. BMJ Open 2014;4:e004549
  • Yang Q, Liu T, Kuklina EV, et al. Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2011;171(13):1183-91
  • Barton P, Andronis L, Briggs A, et al. Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study. BMJ 2011;343:d4044
  • Palar K, Sturm R. Potential societal savings from reduced sodium consumption in the U.S. adult population. Am J Health Promot 2009;24:49-57
  • Ubeda A, Llopico J and Sanchez MT. Blood pressure reduction in hypertensive patients after withdrawal of effervescent medication. Pharmacoepidemiol Drug Saf 2009;18:417-19
  • Douglas L, Akil M. Sodium in soluble paracetamol may be linked to raised blood pressure. BMJ 2006;332:1133
  • George J, Majeed W, Mackenzie IS, et al. Association between cardiovascular events and sodium-containing effervescent, dispersible, and soluble drugs: nested case-control study. BMJ 2013;347:f6954
  • Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86
  • Li XY, Cai XL, Bian PD, Hu LR. High salt intake and stroke: meta-analysis of the epidemiologic evidence. CNS NeurosciTher 2012;18:691-701
  • Yang Q, Liu T, Kuklina EV, et al. Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2011;171:1183-91
  • Arguedas JA, Leiva V, Wright JM. Blood pressure targets for hypertension in people with diabetes mellitus. Cochrane Database Syst Rev 2013;10:CD008277
  • Strazzullo P, Cairella G, Campanozzi A, et al. GIRCSI Working Group. Population based strategy for dietary salt intake reduction: Italian initiatives in the European framework. Nutr Metab Cardiovasc Dis 2012;22:161-6
  • Li N, Yan LL, Niu W, et al. A large-scale cluster randomized trial to determine the effects of community-based dietary sodium reduction–the China Rural Health Initiative Sodium Reduction Study. Am Heart J 2013;166:815-22
  • McCarron DA, Geerling JC, Kazaks AG, Stern JS. Can dietary sodium intake be modified by public policy? Clin J Am Soc Nephrol 2009;4:1878-82
  • Legetic B, Campbell N. Reducing salt intake in the Americas: pan American Health Organization actions. J Health Commun 2011;16(Suppl 2):37-48
  • Shankar B, Brambila-Macias J, Traill B, et al. An evaluation of the UK Food Standards Agency’s salt campaign. Health Econ 2013;22:243-50
  • Sutherland J, Edwards P, Shankar B, Dangour AD. Fewer adults add salt at the table after initiation of a national salt campaign in the UK: a repeated cross-sectional analysis. Br J Nutr 2013;110:552-8
  • Ji C, Kandala NB, Cappuccio FP. Spatial variation of salt intake in Britain and association with socioeconomic status. BMJ Open 2013;3:e002246
  • Duerden M, Avery T, Payne R. Polypharmacy and medicines optimisation: making it safe and sound. Available from: www.kingsfund.org.uk/sites/files/kf/field/field_publication_file/polypharmacy-and-medicines-optimisation-kingsfund-nov13.pdf [Accessed on 31 July 2014]
  • George J, Majeed W, Mackenzie I, et al. Salt in effervescent and dispersible medications: prescriber beware. Prescriber Journal 2014;25:6-8
  • Wei L, Wang J, Thompson P, et al. Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart 2002;88:229-33

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.